In children with perimembranous ventricular septal defects (VSDs), closure with a catheter-delivered occluder device is safe, providing midterm outcomes similar to those of open-heart surgery, ...
Varanasi: Doctors at the department of cardiology at the Institute of Medical Sciences (IMS), Banaras Hindu University (BHU), successfully performed a complex ventricular septal defect (VSD) device ...
New transcatheter device for closing postinfarction ventricular septal defects may be safer than sur
Chicago, IL - A nonrandomized trial of a new ventricular septal occluder designed specifically for the closure of defects that occur post-MI suggests that while mortality is still high following the ...
Muscular ventricular septal defects (mVSD) appearing together with other septal defects are frequently regarded as ‘concomitant’ pathologies, that nevertheless should be considered while the patient ...
April 10, 2009 (Boston, Massachusetts and Vancouver, British Columbia) — The FDA has granted premarket approval to the Starflex device (NMT Medical) for the treatment of ventricular septal defects ...
BOSTON, MA—Rare, postinfarction ventricular septal defects (VSDs), which saw a worrisome resurgence during the COVID-19 pandemic, can effectively be treated surgically or percutaneously, with similar ...
After bicuspid aortic valve, ventricular septal defects (VSDs) are the most common congenital heart abnormalities. Of all congenital defects, around 20% are solitary lesions and another 10% are ...
St. Joseph Hospital ’s Dr. Berdjis Performs Life-Saving Procedure First Time Done in Orange County , California Orange County, Calif. – Heart specialists at St. Joseph Hospital in Orange , Calif. have ...
Current evidence on the safety and efficacy of transcatheter endovascular closure of perimembranous ventricular septal defect (VSD) is adequate to support the use of this procedure provided that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback